The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

36 articles for A Buschauer


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.EBI
University of Regensburg
Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.EBI
University of Regensburg
Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.EBI
University of Regensburg
Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2.EBI
Max Planck Institute of Psychiatry
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.EBI
University of Regensburg
Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor.EBI
University of Regensburg
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.EBI
University of Regensburg
Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.EBI
University of Regensburg
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.EBI
University of Regensburg
N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.EBI
University of Regensburg
Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.EBI
Freie Universit£T Berlin
Novel azulene derivatives for the treatment of erectile dysfunction.EBI
Friedrich-Alexander University
The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H2 receptor agonists.EBI
University of Regensburg
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.EBI
University of Regensburg
Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.EBI
University of Regensburg
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.EBI
University of Regensburg
Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).EBI
Universidad Nacional De Colombia
Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.EBI
Universit£T Regensburg
N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.EBI
UniversitäT Regensburg
Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.EBI
University of Regensburg
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.EBI
UniversitäT Regensburg
Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.EBI
The University of Kansas
Abolishing Dopamine DEBI
University of Regensburg
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the HEBI
University of Regensburg
Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).EBI
University of Regensburg
Fluorescent HEBI
University of Regensburg
UR-DEBa242: A Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine HEBI
University of Regensburg
Alkyl derivatives of 1,3,5-triazine as histamine HEBI
Jagiellonian University Medical College
High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and Radiolabeling.EBI
University of Regensburg
Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.EBI
University of Regensburg
[EBI
University of Regensburg
N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.EBI
Cnrs/Ipbs (Institut De Pharmacologie Et Biologie Structurale)
Histamine H4 receptor agonists.EBI
University of Regensburg
Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators.EBI
Universidad Nacional De Colombia-Sede Bogot£
 
Host properties of cyclodextrins towards anion constituents of antigenic determinants. A thermodynamic study in water and in N,N-dimethylformamideBDB
University of Surrey